| High‐throughput molecular assays for inclusion in personalised oncology trials–State‐of‐the‐art and beyond A Edsjö, HG Russnes, J Lehtiö, D Tamborero, E Hovig, A Stenzinger, ... Journal of internal medicine, 2024 | | 2024 |
| Long-term cardiac effects of modern treatment for Hodgkin’s lymphoma AW Bjerring, KHB Smeland, T Stokke, KH Haugaa, E Holte, A Rösner, ... Cardio-Oncology 10 (1), 19, 2024 | | 2024 |
| Cardiovascular diseases after high‐dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population‐based study J Baech, S Husby, T Trab, K Kragholm, P Brown, JS Gørløv, ... British Journal of Haematology, 2023 | 1 | 2023 |
| 134P A phase I study exploring the safety and tolerability of the small molecule PD-L1 inhibitor INCB099318 in select advanced solid tumors DJ Pinato, U Banerji, S Rottey, K Peltola, J Yachnin, R Kristeleit, ... Immuno-Oncology and Technology 20, 2023 | 1 | 2023 |
| Favorable Outcomes of Splenic Marginal Zone Lymphoma in an International Study of 934 Patients with Long Follow-up AL Al-Mashhadi, MRR Simonsen, CY Cheah, RM Amini, B Arboe, ... Blood 142, 4396, 2023 | | 2023 |
| 2134P Self-reported late effects, need for information and follow-up in long-term Hodgkin lymphoma survivors LH Willumsen, KB Smeland, SA Eikeland, A Fossa, H Bersvendsen, ... Annals of Oncology 34, S1113, 2023 | | 2023 |
| Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway—A population‐based matched cohort study JP Entrop, CE Weibull, KE Smedby, LH Jakobsen, AK Øvlisen, D Molin, ... International Journal of Cancer 153 (4), 723-731, 2023 | | 2023 |
| Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects AA Dahl, KB Smeland, S Eikeland, UM Fagerli, HS Bersvendsen, A Fosså, ... Journal of Cancer Survivorship, 1-10, 2023 | | 2023 |
| Reproduction patterns among non‐Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population‐based matched cohort study JP Entrop, CE Weibull, KE Smedby, LH Jakobsen, AK Øvlisen, I Glimelius, ... British Journal of Haematology 202 (4), 785-795, 2023 | 2 | 2023 |
| Health-related quality of life, depressive symptoms, and chronic fatigue in long-term survivors of Hodgkin lymphoma MS Gulbrandsen, AS Nøding, KB Smeland, SA Eikeland, CE Kiserud, ... Leukemia & Lymphoma 64 (6), 1139-1150, 2023 | 1 | 2023 |
| Chronic fatigue in long-term survivors of Hodgkin’s lymphoma after contemporary risk-adapted treatment SA Eikeland, KB Smeland, VC Simensen, UM Fagerli, HS Bersvendsen, ... Acta Oncologica 62 (1), 80-88, 2023 | 7 | 2023 |
| Reproduktiv Patterns Among Non-Hodgkin Lymphoma Survivors By Subtype in Sweden, Denmark and Norway JPP Entrop, CE Weibull, KE Smedby, LH Jakobsen, AK Oevlisen, ... Blood 140 (Supplement 1), 1079-1081, 2022 | | 2022 |
| Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life K Smeland, H Holte, UM Fagerli, H Bersvendsen, MJ Hjermstad, JH Loge, ... Haematologica 107 (11), 2698, 2022 | 6 | 2022 |
| 622 A phase 1 study exploring the safety and tolerability of the small-molecule PD-L1 inhibitor, INCB099318, in patients with select advanced solid tumors D Pinato, R Plummer, M Gutierrez, J Yachnin, A Schiza, M Hojgaard, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| Long-term cardiac adverse effects after modern Hodgkins lymphoma treatment AW Bjerring, KHB Smeland, I Baerug, KH Haugaa, CE Kiserud, ... European Heart Journal 43 (Supplement_2), ehac544. 801, 2022 | | 2022 |
| T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway JP Entrop, CE Weibull, KE Smedby, LH Jakobsen, D Molin, I Glimelius, ... HemaSphere 6, 30, 2022 | | 2022 |
| Late-effect awareness and follow-up of cancer in general practice SA Eikeland, KB Smeland, M Brekke, CE Kiserud, A Fosså Scandinavian Journal of Primary Health Care 40 (3), 360-369, 2022 | 1 | 2022 |
| P1093: A NEW PROGNOSTIC MODEL FOR INDIVIDUAL OUTCOME PREDICTION IN ADVANCED-STAGE HODGKIN LYMPHOMA. RRK Jørgensen, S Eloranta, MT Severinsen, AK Øvlisen, KB Smeland, ... HemaSphere 6, 983-984, 2022 | | 2022 |
| S202: CHILDBEARING AMONG CLASSICAL HODGKIN LYMPHOMA SURVIVORS TREATED WITH BEACOPP AND ABVD IN SWEDEN, DENMARK, AND NORWAY JP Entrop, CE Weibull, KE Smedby, LH Jakobsen, AK Øvlisen, D Molin, ... HemaSphere 6, 103-104, 2022 | | 2022 |
| Re: Sexual Dysfunction Is Prevalent in Female Lymphoma Survivors after Autologous Stem-Cell Transplantation and Is Associated with Younger Age, Chronic Fatigue, and Mental … HS Bersvendsen, HS Haugnes, AA Dahl, UM Fagerli, O Fluge, H Holte, ... JOURNAL OF UROLOGY 207 (3), 720-720, 2022 | | 2022 |
